DISCOUNT ZERTIFIKAT - BIOGEN IDEC | Delayed Deutsche Boerse AG 01:50:10 2024-06-17 pm EDT | ||
| 211 EUR | -1.42% |
|
| Current month | +2.95% | ||
| 1 month | +1.43% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-17 | 211 | -1.42% |
| 24-06-14 | 214 | -0.27% |
| 24-06-13 | 214.6 | +2.06% |
| 24-06-12 | 210.3 | +0.48% |
| 24-06-11 | 209.3 | -0.03% |
Delayed Quote Deutsche Boerse AG
Last update June 17, 2024 at 01:50 pm EDT
More quotesStatic data
| Product type | Discount Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VM5US5 |
| ISIN | DE000VM5US54 |
| Date issued | 2023-11-22 |
| Maturity | 2024-09-20 (95 Days) |
| Parity | 1 : 1 |
| Emission price | 203.3 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 219.6 € |
|---|---|
| Lowest since issue | 178.5 € |
| Spread | 2.12 € |
| Spread % | 1.00% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
226.5
USD
Average target price
284.6
USD
Spread / Average Target
+25.69%
- Stock Market
- Certificates
- Certificat
